Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2003
03/27/2003US20030060477 Administering to a patient a betablocker and a cholesterol-lowering agent to treat atherosclerosis, hyperpoproteinemia and hypercholesterolemia
03/27/2003US20030060464 Therapeutic 1H-pyrido [ 4, 3-b ] indoles
03/27/2003US20030060462 Therapeutic compounds
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003US20030060458 Indoles and indolines having 5-HT activity
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030060449 Nutraceuticals for treatment of leukemia and solid tumors
03/27/2003US20030060428 Bicyclo (3.2.1)octane in a double ring system having a basic chemical skeletal of a kaurene structure that responds only at elevated plasma glucose concentrations
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans
03/27/2003US20030059495 Compositions for appetite control and related methods
03/27/2003US20030059458 Encapsulated carob fibers having improved product properties, process for production thereof and use thereof
03/27/2003US20030059457 Phaseolamin compositions and methods for using the same
03/27/2003US20030059430 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059420 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059403 Phaseolamin compositions and methods for using the same
03/27/2003US20030059399 Such as poly(N-(2-hydroxy)ethyl ethylenimine) conjugated with 4-(14'-hydroxy-3'-1'ketotetradecyl)phenylboronic acid for inhibiting the uptake of fat in the gastrointestinal tract; dietetics; side effects reduction
03/27/2003DE20219658U1 Composition for reducing body weight, contains swellable compound, preferably polysaccharide, to give satiation effect and nutrients and/or active agents for retarded release
03/27/2003CA2460824A1 Composition for reducing appetite in mammals comprising proxyanidin
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
03/27/2003CA2460719A1 Igf-binding protein-derived peptide or small molecule
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460578A1 Propanolamine derivative having 1,4-benzodioxane ring
03/27/2003CA2460544A1 Anti-inflammatory agent
03/27/2003CA2460537A1 Compositions for appetite control and related methods
03/27/2003CA2460512A1 Thiazolidine derivatives and medicinal use thereof
03/27/2003CA2460150A1 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
03/27/2003CA2460126A1 Tricyclic indole derivatives as 5-ht ligands
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295939A1 Insulin-like growth factor binding protein
03/26/2003EP1295885A1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
03/26/2003EP1295875A1 Heterocyclic compounds
03/26/2003EP1295871A1 Vitamin d derivatives
03/26/2003EP1295609A1 Drugs containing combined active ingredients
03/26/2003EP1295538A2 Encapsulated locust bean fibre with improved properties, process for making it and use thereof
03/26/2003EP1295535A2 Phaseolamin compositions and methods for using the same
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294881A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier
03/26/2003EP1294877A2 Cgi-69 compositions and methods of use
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294873A1 Tumour suppressor and uses thereof
03/26/2003EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
03/26/2003EP1294867A1 Human site-1 protease promoter
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294761A2 Method for activating peroxisome proliferator activated receptor-gamma
03/26/2003EP1294757A2 Glucagon-like peptide-1 analogs
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/26/2003EP1294737A1 Antisense modulation of c/ebp beta expression
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294719A1 Melanocortin receptor ligands
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294682A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
03/26/2003EP1294681A2 Fmoc-l-leucine and derivatives thereof as ppar- gamma agonists
03/26/2003EP1294393A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
03/26/2003EP1294392A2 Materials and methods relating for the treatment and diagnosis of pre-eclampsia
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294367A2 Oral compositions comprising host-response modulating agent
03/26/2003EP1294240A2 Compositions and methods for body weight management
03/26/2003EP1263466A4 Methods and compositions for dietary supplements
03/26/2003EP1181010A4 Pharmaceutical chewing gum formulations
03/26/2003EP1175420B1 Process for preparing n6-substituted deaza-adenosine derivatives
03/26/2003EP1173215A4 Over-coated chewing gum formulations
03/26/2003EP1140917B1 S-oxide lipid lowering compounds
03/26/2003EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
03/26/2003EP1086249B1 Diagnostic method based on quantification of extramitochondrial dna
03/26/2003EP1028717B1 Unsubstituted polydiallylamine for treating hypercholesterolemia
03/26/2003EP0998477B1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
03/26/2003CN1406243A Memno peptides, a process for their preparation and their use
03/26/2003CN1406234A 8,8A-dihydro-indeno [1,2-D] thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1406131A Sympathetic-activating perfume composition
03/26/2003CN1406127A Thiazolium compounds and treatments of disorders associated with protein aging
03/26/2003CN1404852A Medicine for treating diabetes and its preparation method
03/26/2003CN1404848A Fat-reducing Chinese medicine and preparation method thereof
03/26/2003CN1404843A Six-medicine sugar-reducing tea and processing method thereof
03/26/2003CN1404832A Gliclazide oral tablet capable of quickly disintegrating and dissolving out and its preparation technology
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1298